Welcome to our dedicated page for Justera Health news (Ticker: SCRSF), a resource for investors and traders seeking the latest updates and insights on Justera Health stock.
Justera Health Ltd (SCRSF) is a Canadian innovator blending personalized healthcare services with advanced cannabis extraction technologies. This news hub provides investors and stakeholders with comprehensive updates on corporate developments, strategic initiatives, and market positioning.
Access authoritative information about earnings announcements, partnership agreements, product launches, and regulatory milestones. Our curated collection features press releases detailing the company's expansion in wellness therapies, solventless cannabis extraction capabilities through Port North, and emerging ventures in adjacent industries.
Key updates include acquisition disclosures, financial reporting timelines, and operational advancements across three core segments: clinical wellness services, cannabis product innovation, and strategic business diversification. Bookmark this page for real-time access to verified information supporting informed analysis of SCRSF's market trajectory.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has signed a definitive agreement to acquire 100% of Port North Extracts Inc., a solventless cannabis brand. The transaction involves Justera issuing 80,000,000 common shares at a deemed value of $0.02 per share to Port North shareholders. Additionally, Port North warrants will be exchanged for Justera warrants exercisable at $0.05 per share. The acquisition aligns with Justera's strategy to diversify its portfolio and expand in the health and wellness sector, particularly in the cannabis market. Joshua Herman, Port North's CEO, is expected to join Justera's Board of Directors. The deal is subject to closing conditions, including regulatory approval and Port North having a minimum cash on hand of $150,000.
Justera Health has signed a non-binding Letter of Intent (LOI) to acquire all outstanding shares of Port North Extracts, a leading solventless cannabis brand. The acquisition involves issuing 110 million Justera shares at $0.02 each, valued at $2.2 million. Port North is raising $600K through a financing initiative. The completion of the transaction depends on meeting several conditions, including regulatory approvals and Port North having $600K in cash by closing. This acquisition aims to enhance Justera's product offerings and expand its market presence.
Justera Health (OTC Pink: SCRSF) announces a delay in filing its audited annual financial statements, which may lead to a failure-to-file cease trade order by the OSC. The Company is working to finalize the filings promptly to resume normal trading conditions.